Literature DB >> 9857859

Expression and distribution of brain natriuretic peptide in human right atria.

K Doyama1, M Fukumoto, G Takemura, M Tanaka, T Oda, K Hasegawa, T Inada, S Ohtani, T Fujiwara, H Itoh, K Nakao, S Sasayama, H Fujiwara.   

Abstract

OBJECTIVES: We investigated expression of brain natriuretic peptide (BNP) as well as atrial natriuretic peptide (ANP) and their genes in human right atria. Their relations with atrial pressure were also examined.
BACKGROUND: The BNP plays a roll in electrolyte-fluid homeostasis such as ANP. The tissue level is reported to be elevated in the failing ventricles. However, expression and transmural distribution of BNP in the atria remain unclear.
METHODS: Expression of ANP and BNP was immunohistochemically investigated in the right atrial (RA) specimens from 21 patients who had undergone cardiac surgery. The mRNA of specimens were quantitatively measured by Northern blot analysis and also evaluated by in situ hybridization. In addition, plasma levels of ANP and BNP were measured in the patients.
RESULTS: The BNP immunoreactivity was diffusely seen in RA tissue of patients with mean RA pressure (mRAP) of 5 mm Hg or more, but it was noted only in the subendocardial half of the atria of those with mRAP less than 5 mm Hg. There was a significant correlation between the incidence of BNP-positive myocytes and mRAP (r = 0.850, p < 0.0001). Conversely, ANP-positive myocytes were found diffusely in all cases. In Northern blot analysis, the mRNAs levels of ANP and BNP in the atrial tissue were positively correlated with the mRAP (ANP, p = 0.775, p < 0.005 and BNP, p = 0.771, p < 0.005). In situ hybridization confirmed these findings. The mRNA levels were significantly correlated to each other (r = 0.845, p < 0.0002). Plasma ANP and BNP levels were elevated in the patients compared with that in controls; however, none were significantly correlated with the mRAP.
CONCLUSIONS: Expression of BNP and BNP mRNA is augmented in the atria with increased pressure, and distributed predominantly in the subendocardial side. The level of BNP mRNA was well correlated with that of ANP mRNA. Thus, these two genes might be commonly regulated in response to atrial pressure.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9857859     DOI: 10.1016/s0735-1097(98)00494-x

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  9 in total

1.  Atrial fibrillation is an independent determinant of increased NT-proBNP levels in outpatients with signs and symptoms of heart failure.

Authors:  Borut Jug; Miran Sebestjen; Miso Sabovic; Maja Pohar; Irena Keber
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

2.  Usefulness of the brain natriuretic peptide to atrial natriuretic peptide ratio in determining the severity of mitral regurgitation.

Authors:  Ken Shimamoto; Miyako Kusumoto; Rieko Sakai; Hirota Watanabe; Syunichi Ihara; Natsuka Koike; Masatoshi Kawana
Journal:  Can J Cardiol       Date:  2007-03-15       Impact factor: 5.223

3.  Association of Longitudinal Changes in Cardiac Biomarkers With Atrial and Ventricular Arrhythmias (from the Atherosclerosis Risk in Communities [ARIC] Study).

Authors:  Parveen K Garg; Faye L Norby; Wendy Wang; Darshan Krishnappa; Elsayed Z Soliman; Pamela L Lutsey; Elizabeth Selvin; Christie M Ballantyne; Alvaro Alonso; Lin Y Chen
Journal:  Am J Cardiol       Date:  2021-08-28       Impact factor: 2.778

4.  Blood-Based Biomarkers to Search for Atrial Fibrillation in High-Risk Asymptomatic Individuals and Cryptogenic Stroke Patients.

Authors:  Elena Palà; Alejandro Bustamante; Jorge Pagola; Jesus Juega; Jaume Francisco-Pascual; Anna Penalba; Maite Rodriguez; Mercedes De Lera Alfonso; Juan F Arenillas; Juan Antonio Cabezas; Soledad Pérez-Sánchez; Francisco Moniche; Reyes de Torres; Teresa González-Alujas; Josep Lluís Clúa-Espuny; Juan Ballesta-Ors; Domingo Ribas; Juan Acosta; Alonso Pedrote; Felipe Gonzalez-Loyola; Delicia Gentile Lorente; Miguel Ángel Muñoz; Carlos A Molina; Joan Montaner
Journal:  Front Cardiovasc Med       Date:  2022-07-04

Review 5.  Prognostic prediction of troponins in cardiac myxoma: case study with literature review.

Authors:  Shi-Min Yuan
Journal:  Rev Bras Cir Cardiovasc       Date:  2015 Mar-Apr

6.  Galectin-3 in patients with atrial fibrillation undergoing radiofrequency catheter ablation.

Authors:  Jelena Kornej; Josephin Schmidl; Laura Ueberham; Silke John; Sait Daneschnejad; Borislav Dinov; Gerhard Hindricks; Volker Adams; Daniela Husser; Andreas Bollmann
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

Review 7.  Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk.

Authors:  Riccardo Sarzani; Francesco Spannella; Federico Giulietti; Paolo Balietti; Guido Cocci; Marica Bordicchia
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-04-04

8.  Significance of NT-pro-BNP in acute exacerbation of COPD patients without underlying left ventricular dysfunction.

Authors:  Muhammad Adrish; Varalaxmi Bhavani Nannaka; Edison J Cano; Bharat Bajantri; Gilda Diaz-Fuentes
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-04-13

9.  Characteristics of acute congestive heart failure with normal ejection fraction and less elevated B-type natriuretic peptide.

Authors:  Ken Shimamoto; Natsuha Koike; Kiyoko Mizuochi; Miho Honma; Yufuko Kasai; Akiko Sakai; Etsuko Fujita; Masatoshi Kawana
Journal:  BMC Cardiovasc Disord       Date:  2009-01-24       Impact factor: 2.298

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.